Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christos Adamopoulos

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Cancer Letters|January 24, 2017
Potential of glycative stress targeting for cancer preventionChristina Piperi, Christos Adamopoulos, Athanasios G Papavassiliou
Trends in Endocrinology and Metabolism: TEM|January 25, 2016
XBP1: A Pivotal Transcriptional Regulator of Glucose and Lipid MetabolismChristina Piperi, Christos Adamopoulos, Athanasios G Papavassiliou
ACS Chemical Neuroscience|February 16, 2026
Neurodevelopmental Impact of Advanced Glycation End Products in Children with Autism Spectrum DisorderGeorgios Spyridon Ousta, Christos Adamopoulos, Christina Piperi
Journal of Cellular and Molecular Medicine|December 19, 2024
STAT5: Understanding the Biology of KRAS<sup>G12D</sup>-Driven Pancreatic CancerKostas A Papavassiliou, Christos Adamopoulos, Athanasios G Papavassiliou
International Journal of Molecular Sciences|February 10, 2024
Inhibition of the RAF/MEK/ERK Signaling Cascade in Pancreatic Cancer: Recent Advances and Future PerspectivesChristos Adamopoulos, Donatella Delle Cave, Athanasios G Papavassiliou
Trends in Cancer|February 23, 2024
Many faces, many places: delving deeper into CAF heterogeneity in NSCLCKostas A Papavassiliou, Christos Adamopoulos, Athanasios G Papavassiliou
Trends in Molecular Medicine|April 15, 2026
β-hydroxybutyrate supplementation boosts the tumor-killing potential of CAR T cellsChristos Adamopoulos, Kostas A Papavassiliou, Athanasios G Papavassiliou
Cell Death Discovery|November 26, 2025
Sulindac as a precision microRNA modulator in early-stage K-Ras-driven oncogenesisChristos Adamopoulos, Kostas A Papavassiliou, Athanasios G Papavassiliou
Trends in Pharmacological Sciences|April 23, 2024
Malolactone strikes: K-Ras-G12D's Achilles' heelChristos Adamopoulos, Kostas A Papavassiliou, Athanasios G Papavassiliou
Trends in Molecular Medicine|April 9, 2024
SOX17: escape route from immune destruction in early CRCKostas A Papavassiliou, Christos Adamopoulos, Athanasios G Papavassiliou
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Cancer Letters|January 24, 2017
Potential of glycative stress targeting for cancer preventionChristina Piperi, Christos Adamopoulos, Athanasios G Papavassiliou
Trends in Endocrinology and Metabolism: TEM|January 25, 2016
XBP1: A Pivotal Transcriptional Regulator of Glucose and Lipid MetabolismChristina Piperi, Christos Adamopoulos, Athanasios G Papavassiliou
ACS Chemical Neuroscience|February 16, 2026
Neurodevelopmental Impact of Advanced Glycation End Products in Children with Autism Spectrum DisorderGeorgios Spyridon Ousta, Christos Adamopoulos, Christina Piperi
Journal of Cellular and Molecular Medicine|December 19, 2024
STAT5: Understanding the Biology of KRAS<sup>G12D</sup>-Driven Pancreatic CancerKostas A Papavassiliou, Christos Adamopoulos, Athanasios G Papavassiliou
International Journal of Molecular Sciences|February 10, 2024
Inhibition of the RAF/MEK/ERK Signaling Cascade in Pancreatic Cancer: Recent Advances and Future PerspectivesChristos Adamopoulos, Donatella Delle Cave, Athanasios G Papavassiliou
Trends in Cancer|February 23, 2024
Many faces, many places: delving deeper into CAF heterogeneity in NSCLCKostas A Papavassiliou, Christos Adamopoulos, Athanasios G Papavassiliou
Trends in Molecular Medicine|April 15, 2026
β-hydroxybutyrate supplementation boosts the tumor-killing potential of CAR T cellsChristos Adamopoulos, Kostas A Papavassiliou, Athanasios G Papavassiliou
Cell Death Discovery|November 26, 2025
Sulindac as a precision microRNA modulator in early-stage K-Ras-driven oncogenesisChristos Adamopoulos, Kostas A Papavassiliou, Athanasios G Papavassiliou
Trends in Pharmacological Sciences|April 23, 2024
Malolactone strikes: K-Ras-G12D's Achilles' heelChristos Adamopoulos, Kostas A Papavassiliou, Athanasios G Papavassiliou
Trends in Molecular Medicine|April 9, 2024
SOX17: escape route from immune destruction in early CRCKostas A Papavassiliou, Christos Adamopoulos, Athanasios G Papavassiliou
Pageof 8